Bedel Financial Consulting, Inc. Pfizer Inc Transaction History

Bedel Financial Consulting, Inc.

$895 Million
Q4 2025

A detailed history of Bedel Financial Consulting, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 33,514 shares of PFE stock, worth $840,531. This represents 0.09% of its overall portfolio holdings.

Number of Shares

33,514

Previous 35,048 4.38%

Holding current value

$840,531

Previous $893,000 5.94%

% of portfolio

0.09%

Previous 0.11%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 28, 2026	SELL	$24.23 - $27.37 $37,168 - $41,985	-1,534 Reduced 4.38%	33,514 $840,000
Q3 2025 Nov 07, 2025	SELL	$23.29 - $25.88 $33,095 - $36,775	-1,421 Reduced 3.9%	35,048 $893,000
Q2 2025 Aug 12, 2025	SELL	$21.59 - $24.84 $6,584 - $7,576	-305 Reduced 0.83%	36,469 $884,000
Q1 2025 May 07, 2025	BUY	$25.01 - $27.13 $48,769 - $52,903	1,950 Added 5.6%	36,774 $931,000
Q4 2024 Feb 06, 2025	BUY	$24.8 - $30.19 $132,159 - $160,882	5,329 Added 18.07%	34,824 $923,000

Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $42,159 - $47,775	1,522 Added 5.44%	29,495 $853,000
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $1,768 - $2,072	70 Added 0.25%	27,973 $782,000
Q1 2024 May 07, 2024	BUY	$25.89 - $29.73 $750 - $862	29 Added 0.1%	27,903 $774,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $41,834 - $54,337	-1,601 Reduced 5.43%	27,874 $802,000
Q3 2023 Feb 08, 2024	SELL	$32.09 - $37.51 $8,471 - $9,902	-264 Reduced 0.89%	29,475 $977,000
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $56,744 - $65,652	1,571 Added 5.58%	29,739 $1.09 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $17,252 - $22,460	-438 Reduced 1.53%	28,168 $1.15 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $66,967 - $87,418	1,604 Added 5.94%	28,606 $1.47 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $81,218 - $99,147	1,856 Added 7.38%	27,002 $1.27 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $109,159 - $129,428	2,346 Added 10.29%	25,146 $1.32 Million
Q1 2022 Apr 19, 2022	BUY	$45.75 - $56.69 $35,502 - $43,991	776 Added 3.52%	22,800 $1.18 Million
Q4 2021 Jan 11, 2022	BUY	$41.32 - $61.25 $8,759 - $12,985	212 Added 0.97%	22,024 $1.3 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $4,788 - $6,151	-122 Reduced 0.56%	21,812 $938,000
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $49,448 - $56,016	1,377 Added 6.7%	21,934 $859,000
Q1 2021 Apr 26, 2021	BUY	$33.49 - $37.77 $91,662 - $103,376	2,737 Added 15.36%	20,557 $745,000
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $5,522 - $7,022	165 Added 0.93%	17,820 $656,000
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $3,175 - $3,725	100 Added 0.57%	17,655 $648,000
Q2 2020 Jul 14, 2020	SELL	$30.12 - $36.54 $38,011 - $46,113	-1,262 Reduced 6.71%	17,555 $574,000
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $10,325 - $14,752	382 Added 2.07%	18,817 $614,000
Q4 2019 Jan 28, 2020	SELL	$32.92 - $37.36 $147,777 - $167,709	-4,489 Reduced 19.58%	18,435 $722,000
Q3 2019 Oct 09, 2019	BUY	$32.49 - $42.13 $4,743 - $6,150	146 Added 0.64%	22,924 $824,000
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $14,865 - $16,691	-402 Reduced 1.73%	22,778 $987,000
Q1 2019 May 02, 2019	BUY	$37.5 - $41.2 $75 - $82	2 Added 0.01%	23,180 $984,000
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $26,236 - $29,912	-682 Reduced 2.86%	23,178 $1.01 Million
Q3 2018 Nov 01, 2018	BUY	$34.47 - $41.81 $22,543 - $27,343	654 Added 2.82%	23,860 $1.05 Million
Q2 2018 Jul 18, 2018	SELL	$32.98 - $35.16 $31,726 - $33,823	-962 Reduced 3.98%	23,206 $842,000
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $95 - $111	3 Added 0.01%	24,168 $858,000
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $803,727 - $852,782	24,165	24,165 $875,000

Others Institutions Holding PFE

# of Institutions

3,382

Shares Held

3.57B

Call Options Held

86.9M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.

Account

Bedel Financial Consulting, Inc. Pfizer Inc Transaction History